Top Markets
#1 Islamic Coin Islamic Coin +155.77%
#2 Siren Siren +36.63%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.27%
#4 Arowana Arowana +18.13%
#5 Cysic Cysic +17.36%
#6 aPriori aPriori +15.54%
#7 PulseChain PulseChain +14.70%
#8 Perle Perle +14.18%
#9 The Grays Currency The Grays Currency +13.97%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +13.23%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
NFL Biosciences S.A. NFL Biosciences S.A.

NFL Biosciences S.A.

ALNFL
Rank in Stocks #31528
Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL... Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S.A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking. Their most advanced therapeutic candidate, NFL-101, derived from tobacco, is currently progressing through Phase III clinical trials specifically designed to combat smoking addiction. Additionally, the company's research pipeline features NFL-201, an extract blending cannabis and tobacco, and NFL-301, a botanical formulation rooted in traditional Chinese medicine, both of which are undergoing preclinical assessment.
Share Price
$1.02
Market Cap
$12.96M
Change (1 day)
-0.92%
Change (1 year)
-43.11%
Country
FR
Trade NFL Biosciences S.A. (ALNFL)

Category

Healthcare
Revenue for NFL Biosciences S.A. (ALNFL)
Revenue in Aug 2026 TTM: 0
According to NFL Biosciences S.A. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NFL Biosciences S.A. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR